Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Quality of life of adolescents with type 1 diabetes (2015)

  • Authors:
  • USP affiliated authors: VIEIRA, SANDRA ELISABETE - FM
  • USP Schools: FM
  • DOI: 10.6061/cl inics/2015(03)04
  • Subjects: ENDOCRINOPATIAS; DIABETES MELLITUS; ADOLESCÊNCIA; QUALIDADE DE VIDA
  • Language: Inglês
  • Imprenta:
  • Source:
    • Título do periódico: Clinics
    • ISSN: 1807-5932
    • Volume/Número/Paginação/Ano: v. 70, n. 3, p. 173-179, 2015
  • Acesso online ao documento

    DOI or search this record in
    Informações sobre o DOI: 10.6061/cl inics/2015(03)04 (Fonte: oaDOI API)
    • Este periódico é de acesso aberto
    • Este artigo NÃO é de acesso aberto
    Versões disponíveis em Acesso Aberto do: 10.6061/cl inics/2015(03)04 (Fonte: Unpaywall API)

    Título do periódico: Osteoporosis International

    ISSN: 0937-941X,1433-2965



      Não possui versão em Acesso aberto
    Informações sobre o Citescore
  • Título: Clinics

    ISSN: 1807-5932

    Citescore - 2017: 1.44

    SJR - 2017: 0.536

    SNIP - 2017: 0.884


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FM2700545-10BCSEP 063 2015
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      COSTA, Luce Marina F. C. da; VIEIRA, Sandra E. Quality of life of adolescents with type 1 diabetes. Clinics, São Paulo, v. 70, n. 3, p. 173-179, 2015. DOI: 10.6061/cl inics/2015(03)04.
    • APA

      Costa, L. M. F. C. da, & Vieira, S. E. (2015). Quality of life of adolescents with type 1 diabetes. Clinics, 70( 3), 173-179. doi:10.6061/cl inics/2015(03)04
    • NLM

      Costa LMFC da, Vieira SE. Quality of life of adolescents with type 1 diabetes. Clinics. 2015 ; 70( 3): 173-179.
    • Vancouver

      Costa LMFC da, Vieira SE. Quality of life of adolescents with type 1 diabetes. Clinics. 2015 ; 70( 3): 173-179.

    Referências citadas na obra
    Lee C, Ramsey-Goldman R (2005) Osteoporosis in systemic lupus erythematosus mechanisms. Rheum Dis Clin North Am 31:363–385
    Sinigaglia L, Varenna M, Girasole G, Bianchi G (2006) Epidemiology of osteoporosis in in Rheumatic diseases. Rheum Dis Clin North Am 32:631–658
    Pereira RM, Carvalho JF, Canalis E (2010) Glucocorticoid-induced osteoporosis in rheumatic diseases. Clinics (Sao Paulo) 65:1197–1205
    Regio P, Bonfá E, Takayama L, Pereira R (2008) The influence of lean mass in trabecular and cortical bone in juvenile onset systemic lupus erythematosus. Lupus 17:787–792
    Sinigaglia L, Varenna M, Binelli L, Zucchi F, Ghiringhelli D, Fantini F (2000) Bone mass in systemic lupus erythematosus. Clin Exp Rheumatol 18:S27–S34
    Bultink IEM, Lems WF, Kostense PJ, Dijkmans BAC, Voskuyl AE (2005) Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis & Rheumatism 54:2044–2050
    Arko B, Prezelj J, Komel R, Kocijancic A, Hudler P, Marc J (2002) Sequence variations in the osteoprotegerin gene promoter in patients with postmenopausal osteoporosis. J Clin Endocrinol Metab 87:4080–4084
    Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T et al (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165–176
    Mencej-Bedrac S, Prezelj J, Marc J (2011) TNFRSF11B gene polymorphisms 1181G>C and 245T>G as well as haplotype CT influence bone mineral density in postmenopausal women. Maturitas 69:263–267
    Bezerra MC, Carvalho JF, Prokopowitsch AS, Pereira RM (2005) RANK, RANKL and osteoprotegerin in arthritic bone loss. Braz J Med Biol Res 38:161–170
    Lane NE (2006) Therapy Insight: osteoporosis and osteonecrosis in systemic lupus erythematosus. Nat Clin Pract Rheumatol 2:562–569
    Bhalla AK (2010) Management of osteoporosis in a pre-menopausal woman. Best Pract Res Clin Rheumatol 24:313–327
    Tan W, Wu H, Zhao J, Derber LA, Lee DM, Shadick NA et al (2010) A functional RANKL polymorphism associated with younger age at onset of rheumatoid arthritis. Arthritis Rheum 62:2864–2875
    Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, Gudbjartsson DF, Walters GB, Ingvarsson T et al (2008) Multiple genetic loci for bone mineral density and fractures. N Engl J Med 358:2355–2365
    Langdahl BL, Carstens M, Stenkjaer L, Eriksen EF (2002) Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures. J Bone Miner Res 17:1245–1255
    Piedra M, García-Unzueta MT, Berja A, Paule B, Lavin BA, Valero C, Riancho JA, Amado JÁ (2011) Single nucleotide polymorphism of the OPG/RANKL system genes in primary hyperparathyroidism and their relatioship with bone mineral density. BMC Med Genet 20:168
    Nguyen TV, Eisman JA (2013) Genetic profiling and individualized assessment of fracture risk. Nat Rev Endocrinol 9:153–161
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277
    Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640
    Gladman DD, Goldsmith CH, Urowitz MB, Bacon P, Fortin P, Ginzler E et al (2000) The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol 27:373–376
    Lewiecki EM, Gordon CM, Baim S, Leonard MB, Bishop NJ, Bianchi ML et al (2008) International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions. Bone 43:1115–1121
    Obrant KJ, Bengnér U, Johnell O, Nilsson BE, Sernbo I (1989) Increasing age-adjusted risk of fragility fractures: a sign of increasing osteoporosis in successive generations? Calcif Tissue Int 44:157–167
    Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148
    Domiciano DS, Figueiredo CP, Lopes JB, Kuroishi ME, Takayama L, Caparbo VF et al (2013) Vertebral fracture assessment by dual X-ray absorptiometry: a valid tool to detect vertebral fractures in community-dwelling older adults in a population-based survey. Arthritis Care Res (Hoboken) 65:809–815
    Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
    Kirkwood BR, Sterne JAC (2006) Essential medical statistics, 2nd edn. Blackwell Science, Massachusetts, USA, p 502
    Hosmer DW, Lemeshow S (2000) Applied logistic regression, 2ath edn. Wiley, New York, p 320
    Yeap SS, Fauzi AR, Kong NC, Halim AG, Soehardy Z, Rahimah S et al (2009) Influences on bone mineral density in Malaysian premenopausal systemic lupus erythematosus patients on corticosteroids. Lupus 18:178–181
    Grossman JM, Gordon R, Ranganath VK, Deal C, Caplan L, Chen W et al (2010) American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthr Care Res (Hoboken) 62:1515–1526
    Chugh PK (2013) Management of women with systemic lupus erythematosus. Maturitas 75:207–214
    Lopes JB, Fung LK, Cha CC, Gabriel GM, Takayama L, Figueiredo CP, Pereira RM (2012) The impact of asymptomatic vertebral fractures on quality of life in older community-dwelling women: the São Paulo Ageing & Health Study. Clinics (Sao Paulo) 67:1401–1406
    Miyagawa H, Yamai M, Sakaguchi D, Kiyohara C, Tsukamoto H, Kimoto Y et al (2008) Association of polymorphisms in complement component C3 gene with susceptibility to systemic lupus erythematosus. Rheumatology 47:158–164
    Kim JG, Kim JH, Kim JY, Ku SY, Jee BC, Suh CS, Kim SH, Choi YM (2007) Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women. Menopause 14(5):913–918
    Rhee EJ, Yun EJ, Oh KW, Park SE, Park CY, Lee WY, Park SW, Kim SW, Baek KH, Kang MI (2010) The relationship between receptor activator of nuclear factor-kappaB ligand (RANKL) gene polymorphism and aortic calcification in Korean women. Endocr J 57(6):541–549
    Kearns AE, Khosla S, Kostenuik PJ (2008) Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr Rev 29:155–192
    Hawa G, Brinskelle-Schmal N, Glatz K, Maitzen S, Woloszczuk W (2003) Immunoassay for soluble RANKL (receptor activator of NF-B ligand) in serum. Clin Lab 49:461–463
    Ueland T, Bollerslev J, Wilson SG, Dick IM, Islam FM, Mullin BH et al (2007) No associations between OPG gene polymorphisms or serum levels and measures of osteoporosis in elderly Australian women. Bone 40:175–181
    Jørgensen HL, Kusk P, Madsen B, Fenger M, Lauritzen JB (2004) Serum osteoprotegerin (OPG) and the A163G polymorphism in the OPG promoter region are related to peripheral measures of bone mass and fracture odds ratios. J Bone Miner Metab 22:132–138